VICKIE CHAPMAN: Open Payments
NPI 1477613990 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 31 payments from 11 companies in 2025. Trend: 2023 $207 · 2024 $407 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $177 |
| Biogen, Inc. | 5 | $139 |
| Exeltis, USA Inc. | 4 | $70 |
| Sumitomo Pharma America, Inc. | 4 | $65 |
| Lilly USA, LLC | 3 | $55 |
| SHIELD THERAPEUTICS INC | 2 | $35 |
| Becton, Dickinson and Company | 1 | $30 |
| Boston Scientific Corporation | 1 | $22 |
| Baxter Healthcare | 1 | $17 |
| Organon LLC | 1 | $16 |
Products named: Veozah, ZURZUVAE, SLYND, ZEPBOUND, MYFEMBREE, ACCRUFER, ARISTA, General - Female SUI.
Industry payments across GA — which companies pay providers there.
